Plus Therapeutics Key Ratios (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)						-7,149.32%	-4,455.12%	-954.20%	-143.84%	-259.60%	-301.37%	-194.45%	-285.93%	-259.82%	-282.79%	-385.55%	-108.71%	-316.69%	-382.44%	-675.68%
EBIT Margin (Quarter)						-6,978.08%	-4,387.40%	-944.40%	-78.42%	-262.18%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%	-692.51%
EBITDA Margin (Quarter)						-6,978.08%	-4,387.40%	-944.40%	-78.42%	-262.18%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%	-692.51%
Operating Margin (Quarter)						-6,978.08%	-4,387.40%	-944.40%	-78.42%	-262.18%	-293.83%	-196.72%	-289.05%	-260.92%	-276.20%	-333.90%	-110.65%	-320.83%	-420.04%	-692.51%
Net Margin (Quarter)						-7,149.32%	-4,455.12%	-954.20%	-143.84%	-259.60%	-301.37%	-194.45%	-285.93%	-259.82%	-282.79%	-385.55%	-108.71%	-316.69%	-382.44%	-675.68%
FCF Margin (Quarter)						-4,427.40%	-4,129.92%	-1,178.00%	-146.79%	-194.27%	48.29%	-271.50%	-96.25%	-253.71%	-86.54%	-583.10%	-417.63%	-183.04%	-461.23%	-686.38%
Efficiency
Inventory Average (Quarter)
Assets Average (Quarter)	19.59M	22.79M	23.37M	23.25M	22.89M	22.19M	23.49M	19.75M	14.92M	13.74M	12.33M	8.50M	8.42M	9.10M	6.81M	9.34M	11.20M	14.51M	17.50M	18.12M
Invested Capital (Quarter)	6.62M	6.75M	1.61M	1.61M	1.61M	1.61M	1.61M	5.06M	4.71M	4.35M	3.98M	3.59M	3.29M	3.29M	3.29M				0.75M	0.67M
Asset Utilization Ratio (Quarter)				0.13	0.09	0.03	0.01	0.04	0.17	0.27	0.40	0.72	0.65	0.63	0.86	0.56	0.47	0.36	0.30	0.29
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-11.24	-17.50	7.97	-19.63	-25.60	-29.45	-35.04	-47.22	-1.09	-37.37	-18.46	-97.03	-136.93	-59.36	-26.53	-6.45		-0.00M	11.84	-418.76
Debt Ratio (Quarter)	0.32	0.27	0.30	0.26	0.28	0.25	0.23	0.32	0.33	0.33	0.35	0.64	0.29	0.47	0.50				0.05	0.03
Times Interest Earned (Quarter)	-11.24	-17.50	7.97	-19.63	-25.60	-29.45	-35.04	-47.22	-1.09	-37.37	-18.46	-97.03	-136.93	-59.36	-26.53	-6.45		-0.00M	11.84	-418.76
Valuation
Enterprise Value (Quarter)	-17.16M	-21.28M	-18.40M	-21.24M	-18.09M	-20.27M	-18.12M	-12.72M	-10.89M	-11.01M	-8.55M	-2.14M	-8.44M	-4.79M	-3.61M	-9.87M	-6.88M	-16.60M	-8.86M	-15.11M
Return Ratios
Return on Sales (Quarter)				-0.05%	-0.08%	-0.71%	-0.45%	-0.10%	-0.01%	-0.03%	-0.03%	-0.02%	-0.03%	-0.03%	-0.03%	-0.04%	-0.01%	-0.03%	-0.04%	-0.07%
Return on Capital Employed (Quarter)	-87.66%	-89.81%	-71.40%	-76.06%	-103.53%	-122.42%	-169.44%	-294.80%	-479.69%	-469.92%	-829.45%	628.03%	136.01%	485.68%	168.03%	1,229.48%	-328.61%	-1,505.15%	-295.13%	-185.74%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.02%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Datasets

Plans

Developers

Cerenome PSTV Ratios (2010-2026)

Research Tools

Datasets

Plans

Developers

Cerenome PSTV Ratios (2010-2026)

Create an account

Sign In

Reset Password